Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 282 results in range #551 to #832.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Translocation‏‎ (1 revision)
  2. Multistage carcinogenesis model‏‎ (1 revision)
  3. ICRP Publication 2‏‎ (1 revision)
  4. ICRP Publication 30 (Part 3)‏‎ (1 revision)
  5. Derived consideration reference level‏‎ (1 revision)
  6. ICRP Publication 40‏‎ (1 revision)
  7. Phantom‏‎ (1 revision)
  8. ICRP Publication 55‏‎ (1 revision)
  9. Dose conversion convention‏‎ (1 revision)
  10. ICRP Publication 7‏‎ (1 revision)
  11. ICRP Publication 84‏‎ (1 revision)
  12. Exclusion‏‎ (1 revision)
  13. Ras‏‎ (1 revision)
  14. Reference phantom‏‎ (1 revision)
  15. Acute exposure‏‎ (1 revision)
  16. ICRP Publication 90‏‎ (1 revision)
  17. Allometry‏‎ (1 revision)
  18. Size-specific dose estimate‏‎ (1 revision)
  19. ICRP Publication 102‏‎ (1 revision)
  20. Specific absorbed fraction‏‎ (1 revision)
  21. ICRP Publication 116‏‎ (1 revision)
  22. ICRP Publication 131‏‎ (1 revision)
  23. Threshold level‏‎ (1 revision)
  24. ICRP Publication 146‏‎ (1 revision)
  25. Concentration ratio‏‎ (1 revision)
  26. ICRP Publication 20‏‎ (1 revision)
  27. ICRP Publication 30 (Part 4)‏‎ (1 revision)
  28. Derived investigation level‏‎ (1 revision)
  29. Organ at risk‏‎ (1 revision)
  30. ICRP Publication 41‏‎ (1 revision)
  31. Directional dose equivalent‏‎ (1 revision)
  32. ICRP Publication 56‏‎ (1 revision)
  33. Dose conversion factor‏‎ (1 revision)
  34. Principles of protection‏‎ (1 revision)
  35. ICRP Publication 70‏‎ (1 revision)
  36. Effect modifier‏‎ (1 revision)
  37. Radiation-induced second cancer‏‎ (1 revision)
  38. ICRP Publication 85‏‎ (1 revision)
  39. Endosteum‏‎ (1 revision)
  40. Rb‏‎ (1 revision)
  41. Reference value‏‎ (1 revision)
  42. ICRP Publication 91‏‎ (1 revision)
  43. Slice‏‎ (1 revision)
  44. Biological half-life‏‎ (1 revision)
  45. ICRP Publication 117‏‎ (1 revision)
  46. ICRP Publication 132‏‎ (1 revision)
  47. Clonogenic surviving fraction‏‎ (1 revision)
  48. Marrow cellularity‏‎ (1 revision)
  49. ICRP Publication 147‏‎ (1 revision)
  50. Cone beam computed tomography‏‎ (1 revision)
  51. Multitarget equation‏‎ (1 revision)
  52. ICRP Publication 21‏‎ (1 revision)
  53. ICRP Publication 30 (Supplement A to Part 3)‏‎ (1 revision)
  54. Derived limit‏‎ (1 revision)
  55. ICRP Publication 42‏‎ (1 revision)
  56. Pilomatricoma‏‎ (1 revision)
  57. ICRP Publication 57‏‎ (1 revision)
  58. ICRP Publication 71‏‎ (1 revision)
  59. Radiation-induced secondary malignancy‏‎ (1 revision)
  60. ICRP Publication 86‏‎ (1 revision)
  61. Radiological attack‏‎ (1 revision)
  62. Reactive oxygen species‏‎ (1 revision)
  63. Reference worker‏‎ (1 revision)
  64. ICRP Publication 92‏‎ (1 revision)
  65. Human Alimentary Tract Model‏‎ (1 revision)
  66. Informed consent‏‎ (1 revision)
  67. ICRP Publication 104‏‎ (1 revision)
  68. Biomarker‏‎ (1 revision)
  69. Spongiosa‏‎ (1 revision)
  70. System of radiological protection‏‎ (1 revision)
  71. ICRP Publication 133‏‎ (1 revision)
  72. Time-resolved computed tomography‏‎ (1 revision)
  73. ICRP Publication 148‏‎ (1 revision)
  74. Mutation component‏‎ (1 revision)
  75. ICRP Publication 22‏‎ (1 revision)
  76. Waste management‏‎ (1 revision)
  77. Normal tissue complication probability‏‎ (1 revision)
  78. ICRP Publication 30 (Supplement B to Part 3)‏‎ (1 revision)
  79. Derived reference level‏‎ (1 revision)
  80. ICRP Publication 43‏‎ (1 revision)
  81. Disposal facility‏‎ (1 revision)
  82. ICRP Publication 58‏‎ (1 revision)
  83. ICRP Publication 72‏‎ (1 revision)
  84. ICRP Publication 87‏‎ (1 revision)
  85. Radiological controlled area‏‎ (1 revision)
  86. Absorption Type‏‎ (1 revision - redirect page)
  87. Referrer‏‎ (1 revision)
  88. Additional dose‏‎ (1 revision)
  89. ICRP Publication 93‏‎ (1 revision)
  90. Ambient dose equivalent‏‎ (1 revision)
  91. ICRU 4-element tissue‏‎ (1 revision)
  92. Human Respiratory Tract Model‏‎ (1 revision)
  93. Automatic exposure control‏‎ (1 revision)
  94. ICRP Publication 105‏‎ (1 revision)
  95. ICRP Publication 119‏‎ (1 revision)
  96. ICRP Publication 134‏‎ (1 revision)
  97. Cobblestone area forming cell assay‏‎ (1 revision)
  98. ICRP Publication 149‏‎ (1 revision)
  99. Treatment preparation in radiotherapy‏‎ (1 revision)
  100. ICRP Publication 23‏‎ (1 revision)
  101. DRL quantity‏‎ (1 revision)
  102. Notification value‏‎ (1 revision)
  103. ICRP Publication 30 (Supplement to Part 1)‏‎ (1 revision)
  104. Designated area‏‎ (1 revision)
  105. Other (systemic) tissues‏‎ (1 revision)
  106. ICRP Publication 44‏‎ (1 revision)
  107. Distribution coefficient‏‎ (1 revision)
  108. ICRP Publication 59‏‎ (1 revision)
  109. ICRP Publication 73‏‎ (1 revision)
  110. ICRP Publication 88‏‎ (1 revision)
  111. Epigenetic effects‏‎ (1 revision)
  112. 1928 Recommendations‏‎ (1 revision)
  113. Region‏‎ (1 revision)
  114. Additive risk projection model‏‎ (1 revision)
  115. ICRP Publication 94‏‎ (1 revision)
  116. ICRU sphere‏‎ (1 revision)
  117. ICRP Publication 106‏‎ (1 revision)
  118. ICRP Publication 12‏‎ (1 revision)
  119. Linear dose response‏‎ (1 revision)
  120. ICRP Publication 135‏‎ (1 revision)
  121. Mean glandular dose‏‎ (1 revision)
  122. ICRP Publication 15‏‎ (1 revision)
  123. Trophic level‏‎ (1 revision)
  124. ICRP Publication 24‏‎ (1 revision)
  125. Nuclear medicine‏‎ (1 revision)
  126. ICRP Publication 30 (Supplement to Part 2)‏‎ (1 revision)
  127. Detector quantum efficiency‏‎ (1 revision)
  128. ICRP Publication 45‏‎ (1 revision)
  129. Pooled analysis‏‎ (1 revision)
  130. ICRP Publication 6‏‎ (1 revision)
  131. ICRP Publication 74‏‎ (1 revision)
  132. Radiation risk‏‎ (1 revision)
  133. ICRP Publication 89‏‎ (1 revision)
  134. Exogenous excretion‏‎ (1 revision)
  135. 1931 Recommendations‏‎ (1 revision)
  136. Regional diagnostic reference levels‏‎ (1 revision)
  137. Adenoma‏‎ (1 revision)
  138. ICRP Publication 95‏‎ (1 revision)
  139. Sealed source‏‎ (1 revision)
  140. Solar flare‏‎ (1 revision)
  141. ICRP Publication 107‏‎ (1 revision)
  142. ICRP Publication 120‏‎ (1 revision)
  143. Carers and comforters‏‎ (1 revision)
  144. ICRP Publication 136‏‎ (1 revision)
  145. Collective dose‏‎ (1 revision)
  146. Tissue reaction‏‎ (1 revision)
  147. Measured quantity‏‎ (1 revision)
  148. ICRP Publication 150‏‎ (1 revision)
  149. Tumour suppressor gene‏‎ (1 revision)
  150. National DRL‏‎ (1 revision)
  151. ICRP Publication 25‏‎ (1 revision)
  152. ICRP Publication 31‏‎ (1 revision)
  153. Deterministic effect‏‎ (1 revision)
  154. Oxygen enhancement ratio‏‎ (1 revision)
  155. ICRP Publication 46‏‎ (1 revision)
  156. Population risk‏‎ (1 revision)
  157. ICRP Publication 60‏‎ (1 revision)
  158. Dose modifying factor‏‎ (1 revision)
  159. ICRP Publication 75‏‎ (1 revision)
  160. ICRP Publication 9‏‎ (1 revision)
  161. 1934 Recommendations‏‎ (1 revision)
  162. Access control‏‎ (1 revision)
  163. Registry‏‎ (1 revision)
  164. General Information: Radon‏‎ (1 revision - redirect page)
  165. ICRP Publication 96‏‎ (1 revision)
  166. Secondary radiation‏‎ (1 revision)
  167. Intake‏‎ (1 revision)
  168. ICRP Publication 108‏‎ (1 revision)
  169. Brachytherapy‏‎ (1 revision)
  170. Standard-size adult‏‎ (1 revision)
  171. ICRP Publication 121‏‎ (1 revision)
  172. Case–control study‏‎ (1 revision)
  173. ICRP Publication 137‏‎ (1 revision)
  174. ICRP Publication 151‏‎ (1 revision)
  175. National radon survey‏‎ (1 revision)
  176. ICRP Publication 26‏‎ (1 revision)
  177. DS86‏‎ (1 revision)
  178. ICRP Publication 32‏‎ (1 revision)
  179. ICRP Publication 47‏‎ (1 revision)
  180. Potential alpha energy concentration‏‎ (1 revision)
  181. ICRP Publication 61‏‎ (1 revision)
  182. ICRP Publication 76‏‎ (1 revision)
  183. Equilibrium equivalent concentration‏‎ (1 revision)
  184. Expanded radiation field‏‎ (1 revision)
  185. 1937 Recommendations‏‎ (1 revision)
  186. Redox‏‎ (1 revision)
  187. Adventitious source‏‎ (1 revision)
  188. ICRP Publication 97‏‎ (1 revision)
  189. Annual intake‏‎ (1 revision)
  190. Secretory cells‏‎ (1 revision)
  191. Intensity-modulated radiotherapy‏‎ (1 revision)
  192. ICRP Publication 109‏‎ (1 revision)
  193. Stem cell‏‎ (1 revision)
  194. Kerma approximation‏‎ (1 revision)
  195. ICRP Publication 122‏‎ (1 revision)
  196. Targeted effects‏‎ (1 revision)
  197. ICRP Publication 138‏‎ (1 revision)
  198. Collimation‏‎ (1 revision)
  199. ICRP Publication 152‏‎ (1 revision)
  200. Typical value‏‎ (1 revision)
  201. ICRP Publication 27‏‎ (1 revision)
  202. ICRP Publication 33‏‎ (1 revision)
  203. Detriment-adjusted risk‏‎ (1 revision)
  204. Particle transport‏‎ (1 revision)
  205. ICRP Publication 48‏‎ (1 revision)
  206. Dose-response function‏‎ (1 revision)
  207. ICRP Publication 62‏‎ (1 revision)
  208. ICRP Publication 77‏‎ (1 revision)
  209. Equilibrium factor‏‎ (1 revision)
  210. 1950 Recommendations‏‎ (1 revision)
  211. Relative biological effectiveness‏‎ (1 revision)
  212. ICRP Publication 98‏‎ (1 revision)
  213. Backscatter factor‏‎ (1 revision)
  214. Somatic effect‏‎ (1 revision)
  215. ICRP Publication 10A‏‎ (1 revision)
  216. ICRP Publication 123‏‎ (1 revision)
  217. Charged-particle equilibrium‏‎ (1 revision)
  218. ICRP Publication 139‏‎ (1 revision)
  219. Tolerance dose‏‎ (1 revision)
  220. ICRP Publication 153‏‎ (1 revision)
  221. ICRP Publication 28‏‎ (1 revision)
  222. Occupancy factor‏‎ (1 revision)
  223. ICRP Publication 34‏‎ (1 revision)
  224. ICRP Publication 49‏‎ (1 revision)
  225. ICRP Publication 63‏‎ (1 revision)
  226. ICRP Publication 78‏‎ (1 revision)
  227. Elemental dose‏‎ (1 revision)
  228. Radon-prone area‏‎ (1 revision)
  229. Exposed individuals‏‎ (1 revision)
  230. 1954 Recommendations‏‎ (1 revision)
  231. Reference Person‏‎ (1 revision)
  232. Relative life lost‏‎ (1 revision)
  233. ICRP Publication 99‏‎ (1 revision)
  234. Apoptosis‏‎ (1 revision)
  235. Security screening‏‎ (1 revision)
  236. ICRP Publication 11‏‎ (1 revision)
  237. Stochastic effect‏‎ (1 revision)
  238. ICRP Publication 124‏‎ (1 revision)
  239. ICRP Publication 125‏‎ (1 revision)
  240. Teratocarcinoma‏‎ (1 revision)
  241. Low dose‏‎ (1 revision)
  242. ICRP Publication 14‏‎ (1 revision)
  243. Commissioning‏‎ (1 revision)
  244. ICRP Publication 154‏‎ (1 revision)
  245. Cosmic radiation‏‎ (1 revision)
  246. ICRP Publication 29‏‎ (1 revision)
  247. ICRP Publication 35‏‎ (1 revision)
  248. ICRP Publication 5‏‎ (1 revision)
  249. Dose-threshold hypothesis‏‎ (1 revision)
  250. Potentially lethal damage repair‏‎ (1 revision)
  251. ICRP Publication 64‏‎ (1 revision)
  252. ICRP Publication 79‏‎ (1 revision)
  253. 1956 Recommendations‏‎ (1 revision)
  254. Activation‏‎ (1 revision)
  255. Relative risk‏‎ (1 revision)
  256. Ring chromosome‏‎ (1 revision)
  257. ICRP Supporting Guidance 2‏‎ (1 revision)
  258. ICRP Publication 1‏‎ (1 revision)
  259. Baseline disease rates‏‎ (1 revision)
  260. International Commission on Radiological Protection‏‎ (1 revision)
  261. ICRP Publication 110‏‎ (1 revision)
  262. Breakpoint cluster region/abelson‏‎ (1 revision)
  263. Lag‏‎ (1 revision)
  264. Late normal tissue responses‏‎ (1 revision)
  265. ICRP Publication 126‏‎ (1 revision)
  266. ICRP Publication 140‏‎ (1 revision)
  267. ICRP Publication 155‏‎ (1 revision)
  268. ICRP Publication 3‏‎ (1 revision)
  269. Α/β value‏‎ (1 revision)
  270. Oncogene‏‎ (1 revision)
  271. ICRP Publication 36‏‎ (1 revision)
  272. Dicentric chromosome‏‎ (1 revision)
  273. ICRP Publication 50‏‎ (1 revision)
  274. Dose and dose-rate effectiveness factor‏‎ (1 revision)
  275. ICRP Publication 65‏‎ (1 revision)
  276. ICRP Publication 8‏‎ (1 revision)
  277. 1959 Decisions‏‎ (1 revision)
  278. Relative survival‏‎ (1 revision)
  279. Hereditary effect‏‎ (1 revision)
  280. ICRP Publication 10‏‎ (1 revision)
  281. Source region‏‎ (1 revision)
  282. ICRP Publication 111‏‎ (1 revision)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://icrpaedia.org/Special:MostRevisions"